phone icon  Toll Free : +1-800-792-5285 | (UK) : + 44-845-528-1300
Allied Market Research

0
Shopping Cart is Empty..
$ 0

Cancer Drugs

allied printing

The global cancer drugs market provides oncological therapeutic products and services for patients. These drugs target the diseased cells in a body and reverse the cell proliferation that results in improvement in overall health conditions. The industry has witnessed substantial growth in terms of revenue and volume due to a rise in incidence rates and augmentation in types of cancer. At present, regulatory concerns, time-consuming clinical trials, and delayed approvals hinder the introduction of proposed drugs on consumer platforms.

However, the latest anti-cancer drugs developed with gene and protein mutations include erythropoietin drugs, biosimilar drugs, and nuclear medicine. The industry analysis encompasses portfolio offerings of renowned pharmaceutical companies in this segment. We also analyze the cost and pricing structures of anti-cancer drugs and their effect on growth patterns across geographies.

 
 
 
Erythropoietin Drugs Market- Global Opportunity Analysis and Industry Forecast, 2013 - 2020
Jan 2015
 
 
Oncology/Cancer Drugs Market- Global Opportunity Analysis and Industry Forecast, 2013 - 2020
Feb 2015
 
 
World Ovarian Cancer Drugs Market- Opportunities and Forecasts, 2014 - 2022
Dec 2017
 
 
Biosimilars Market- Global Opportunity Analysis and Industry Forecast, 2014-2020
Sep 2015
 
 
LAMEA Oncology/Anti-cancer drugs Market- Opportunity Analysis and Industry Forecast, 2014 - 2021
Feb 2016
 
 
Nuclear Medicine Market- Global Opportunity Analysis and Industry Forecast, 2014 - 2022
Jul 2016
 
 
World Prostate Cancer Market- Opportunities and Forecasts, 2014 - 2022
Dec 2017